Valiant Laboratories Q2 Results FY27: Revenue Jumps 152.75% to Rs 116.77 Cr, PAT Rs 0.41 Cr

November 3, 2026
Posted by: Harsh Piplani
Category: Results

Quick Answer

Valiant Laboratories Q2 Results FY27 were published on 2 November 2026 on a Consolidated basis, with revenue of Rs 116.77 Cr and net profit of Rs 0.41 Cr. Revenue grew 152.75% YoY from Rs 46.20 Cr, and net profit rose 105% from Rs 0.20 Cr. Operating Profit reached Rs 5.17 Cr, so these quarterly results show YoY growth across all three lines.

Valiant Laboratories Ltd (VALIANTLAB) Q2 Results FY27 announced on 2 November 2026, covering the company’s financial performance for the July to September quarter. The company reported Consolidated revenue of Rs 116.77 Cr, Operating Profit of Rs 5.17 Cr and PAT of Rs 0.41 Cr. In Valiant Laboratories Q2 Results FY27, the results date and the consolidated results show sales far above the year-ago level.

This Valiant Laboratories Q2 Results results analysis looks at the financial highlights, the disclosed business drivers, the FY27 outlook and the risks. NSE and BSE readers can follow the same data on the Univest Screener, and the table under the next heading sets out each figure.

Click Here – Get Free Investment Predictions

Table of Contents

Valiant Laboratories Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 116.77 Cr	Rs 46.2 Cr	+152.75% YoY
Operating Profit	Rs 5.17 Cr	Rs 0.08 Cr	+6362.5% YoY
Net Profit (PAT)	Rs 0.41 Cr	Rs 0.2 Cr	+105% YoY

Source: company filing for Valiant Laboratories Q2 Results FY27, 2 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Valiant Laboratories Q2 Results: What Stands Out

Revenue of Rs 116.77 Cr compares with Rs 46.20 Cr a year earlier, which is YoY growth of 152.75% for the quarter.
Net profit of Rs 0.41 Cr is up 105% on the Rs 0.20 Cr posted in the year-ago quarter, though the absolute amount is small.
Operating Profit of Rs 5.17 Cr compares with Rs 0.08 Cr a year ago, a YoY rise of 6,362.50% from a very small base.
Four consecutive quarters of rising revenue lead into the latest figure, a run that Valiant Laboratories Q2 Results FY27 extends.
The performance analysis next puts these three lines side by side in rupee terms.

Valiant Laboratories Q2 Results FY27: Performance Analysis

Valiant Laboratories earned consolidated revenue of Rs 116.77 Cr, Operating Profit of Rs 5.17 Cr and net profit of Rs 0.41 Cr for July to September 2026. Revenue grew 152.75% YoY, net profit grew 105% and Operating Profit moved from Rs 0.08 Cr to Rs 5.17 Cr.

The results analysis shows the rupee gains. Revenue added Rs 70.57 Cr over its Rs 46.20 Cr base, and Operating Profit added Rs 5.09 Cr. Net profit added only Rs 0.21 Cr, so the percentage rise of 105% reflects a very small starting figure of Rs 0.20 Cr.

For the Valiant Laboratories Q2 Results reading, the quarterly results show that revenue expanded far more than net profit in absolute terms. Investors will watch whether Operating Profit carries through to the bottom line later, and the results analysis now moves to the business factors in the filing.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Expansion – The results analysis opens with revenue, which grew 152.7% year on year to Rs 116.77 Cr in the latest quarter. This is the largest rupee change in Valiant Laboratories Q2 Results FY27 and sets the scale for the rest.

Net Profit Rise – Net profit rose 105.0% year on year to Rs 0.41 Cr. The quarterly results confirm the direction of profit, although the supplied figures do not establish the specific cause behind the increase.

Four Quarters of Higher Sales – Revenue has risen in each of the last 4 quarters. That sequence means the Rs 116.77 Cr reported now follows three earlier increases and is not a single isolated jump in sales.

FY27 Outlook After Valiant Laboratories Q2 Results

No guidance accompanies the filing, so the FY27 picture depends on the quarters still to be reported. Valiant Laboratories Q2 Results FY27 provides one data point, with consolidated revenue of Rs 116.77 Cr and net profit of Rs 0.41 Cr, for later disclosures to be compared with.

The last five quarters have seen net profit range from a loss of Rs 7.06 Cr to a profit of Rs 21.10 Cr. A results analysis of the next quarter will show where net profit settles within that wide band, and that spread leads straight to the risks. Readers can follow each new filing on the Univest app to see how the consolidated numbers develop.

Key Risks to Watch After Valiant Laboratories Q2 Results FY27

Negative Return on Equity

Return on equity was low at -1.20% in FY26. Strong YoY growth in the latest quarter does not alter that annual reading, so shareholder returns remain something to monitor in later filings.

Modest Return on Capital

Return on capital employed was modest at 0.75% in FY26. The sales gains in Valiant Laboratories Q2 Results FY27 will need to translate into stronger capital returns, and subsequent quarters will show whether that happens.

Wide Swings in Quarterly Profit

Quarterly net profit has been volatile, ranging from Rs -7.06 Cr to Rs 21.10 Cr over the last 5 quarters. The Rs 0.41 Cr reported now sits well inside that band, so steadiness is yet to be seen.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Valiant Laboratories Q2 Results FY27 show consolidated revenue of Rs 116.77 Cr, Operating Profit of Rs 5.17 Cr and net profit of Rs 0.41 Cr, all higher YoY. These quarterly results come with a Valiant Laboratories Q2 Results risk list built around low returns and volatile profit. Readers should consult a SEBI-registered advisor before acting on these consolidated results.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Valiant Laboratories Q2 Results FY27

What are Valiant Laboratories Q2 Results FY27?

Ans. Valiant Laboratories Q2 Results FY27 are the consolidated quarterly results for July to September 2026, with revenue of Rs 116.77 Cr and net profit of Rs 0.41 Cr, as the Quick Answer states.

What is the results date for Valiant Laboratories Q2 Results FY27?

Ans. Valiant Laboratories announced its Q2 FY27 results on 2 November 2026, so the results date refers to the July to September quarter covered in the opening paragraphs.

What revenue was reported in Valiant Laboratories Q2 Results FY27?

Ans. Valiant Laboratories reported consolidated revenue of Rs 116.77 Cr in Q2 FY27, compared with Rs 46.20 Cr a year earlier, as the Financial Highlights table shows.

What net profit was reported in Valiant Laboratories Q2 Results FY27?

Ans. Valiant Laboratories Q2 Results FY27 show net profit of Rs 0.41 Cr against Rs 0.20 Cr in the year-ago quarter, which means net profit rose 105%, as the Key Takeaways section lists.

How much YoY growth did revenue show in Valiant Laboratories Q2 Results FY27?

Ans. Revenue showed YoY growth of 152.75% for Valiant Laboratories in Q2 FY27, while net profit grew 105%, as the Performance Analysis section compares in rupee terms.

Did net profit rise or fall in Valiant Laboratories Q2 Results?

Ans. Net profit rose in Valiant Laboratories Q2 Results, from Rs 0.20 Cr to Rs 0.41 Cr, a gain of Rs 0.21 Cr, as the Performance Analysis explains.

What was the Operating Profit in Valiant Laboratories Q2 Results FY27?

Ans. Operating Profit was Rs 5.17 Cr in Q2 FY27, against Rs 0.08 Cr a year earlier, which means YoY growth from a very small base, as the Key Takeaways show.

Are Valiant Laboratories Q2 Results consolidated results or standalone results?

Ans. Valiant Laboratories Q2 Results are consolidated results, so the Rs 116.77 Cr revenue and Rs 0.41 Cr net profit cover the group, a basis set out in the Quick Answer.

What business factors shaped Valiant Laboratories Q2 Results FY27?

Ans. Revenue growth of 152.7%, net profit growth of 105.0% and four straight quarters of rising revenue shaped Valiant Laboratories this quarter, as the Key Business Factors section details.

What are the key risks after Valiant Laboratories Q2 Results FY27?

Ans. Risks include return on equity of -1.20%, return on capital employed of 0.75% and volatile quarterly net profit, all of which the Key Risks section covers.

What is the outlook after Valiant Laboratories Q2 Results?

Ans. No guidance comes with Valiant Laboratories Q2 Results, so the FY27 outlook depends on later quarters, while the five-quarter net profit range of Rs -7.06 Cr to Rs 21.10 Cr remains the reference.

Where can I find the complete Valiant Laboratories Q2 Results FY27 data?

Ans. The complete Valiant Laboratories Q2 Results FY27 numbers are in the Financial Highlights table above, and the Univest app lists the same revenue, Operating Profit and net profit for VALIANTLAB.

Author: Harsh Piplani

I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.